BioWorld MedTech

Aug. 4, 2010

GenSpera acquires rights to cancer imaging technology

Sometimes having too many choices for something is not a good thing. Other times – as is the case for GenSpera (San Antonio) right now – having a lot of options is a very good thing. (Medical Device Daily) Read More

Report from Europe: GE unit sees $1B opportunity in healthcare reform market

Washington roundup: Maisel to take post at CDRH as head of new science office

New ventures: RHP in opthalmology space with newly launched BVI

Deals roundup: PerkinElmer acquires molecular imaging company VisEn Medical

MDD's food for med-tech thought

Financings roundup: Tenet launches offer of notes due 2013

Agreements/contracts: CardioGenics partners in magnetic bed shipments

People in the News

Med-Tech Notes

Court Report: Federal judge rules lawsuit against healthcare reform valid

Product Briefs

Boston Sci trial 'EVOLVEs' into Synergy assessment

MDD's Oncology Extra

Today's news in brief

BioWorld

Illustration of SCAN in Parkinson’s vs healthy subcortex

SCAN is core circuit affected in Parkinson’s disease

BioWorld Science

Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...

TL1A is overexpressed in hidradenitis suppurativa

BioWorld Science

Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...

IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa

BioWorld Science

Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...

Astellas’ ASP-2246 shows promise in stroke management

BioWorld Science

Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...